Wednesday, July 8, 2026

Drug profile · INN

capreomycin sulfate

capreomycin sulfate (CAPASTAT SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 15
Pipeline programs 2
News articles 0
Drug details — capreomycin sulfate
US status
approved
Class
Route
INJECTION
Patents
15
Programs
2
Data quality
0.84

Quick answer

capreomycin sulfate (CAPASTAT SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN capreomycin sulfate
Brand CAPASTAT SULFATE
Mechanism 70S ribosome inhibitor
Target 70S ribosome
Route INJECTION
Formulation INJECTABLE

Mechanism of action

70S ribosome inhibitor

Primary target: 70S ribosome

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. CaPre Phase 3 · Grace Therapeutics · Hypertriglyceridemia
  2. CaPre (TM) Phase 2 · Grace Therapeutics · Hypertriglyceridemia

Related & competitor drugs

  1. azithromycin Bacterial 70S ribosome inhibitor
  2. chloramphenicol Bacterial 70S ribosome inhibitor
  3. clarithromycin Bacterial 70S ribosome inhibitor
  4. clindamycin hydrochloride Bacterial 70S ribosome inhibitor
  5. clindamycin palmitate hydrochloride Bacterial 70S ribosome inhibitor
  6. clindamycin phosphate Bacterial 70S ribosome inhibitor

Related patents

  1. US 11052029

    Cation compatible metal oxides and oral care compositions containing the metal oxides

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11000711

    Compositions for forming films having a desired degree of obscuration and methods of making and using the same

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 10660856

    Porous silica gel as a carrier for liquid technologies

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 10525290

    Compositions for forming films having a desired degree of obscuration and methods of making and using the same

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7964612

    Therapeutic pyrazolyl thienopyridines

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7820398

    Immunosorbent blood tests for assessing paroxysmal cerebral discharges

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7678918

    Intermediates for imidazonaphthyridines

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7615230

    Method for decreasing sebum production

    Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7335773

    Intermediates for imidazonaphthyridines

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 6896876

    High cleaning silica gel dental abrasive, dentifrices prepared therefrom, and a method for preparing the dental abrasive

    Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  11. US 6585960

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  12. US 6440397

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  13. US 6426201

    &bgr;-glucan products and extraction processes from cereals

    Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  14. US 6294155

    Abrasive silica compositions and dentifrice compositions prepared therefrom

    Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  15. US 6239110

    Synthetic analogs of thrombospondin and therapeutic use thereof

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is capreomycin sulfate?

capreomycin sulfate (CAPASTAT SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for capreomycin sulfate?

CAPASTAT SULFATE is a marketed brand name for capreomycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of capreomycin sulfate?

capreomycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.